Emergent BioSolutions, Inc. (EBS)
6.795
-0.42
(-5.89%)
USD |
NYSE |
Oct 30, 16:00
6.795
0.00 (0.00%)
After-Hours: 18:10
Emergent BioSolutions Cash and Short Term Investments (Annual) : 209.10M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 209.10M |
| December 31, 2024 | 105.60M |
| December 31, 2023 | 111.70M |
| December 31, 2022 | 642.60M |
| December 31, 2021 | 576.30M |
| December 31, 2020 | 621.50M |
| December 31, 2019 | 168.00M |
| December 31, 2018 | 112.40M |
| December 31, 2017 | 179.30M |
| December 31, 2016 | 271.51M |
| December 31, 2015 | 308.30M |
| Date | Value |
|---|---|
| December 31, 2014 | 280.50M |
| December 31, 2013 | 179.34M |
| December 31, 2012 | 141.67M |
| December 31, 2011 | 146.09M |
| December 31, 2010 | 171.26M |
| December 31, 2009 | 103.14M |
| December 31, 2008 | 91.47M |
| December 31, 2007 | 105.73M |
| December 31, 2006 | 76.42M |
| December 31, 2005 | 87.99M |
| December 31, 2004 | 8.071M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Exelixis, Inc. | 1.059B |
| Arcturus Therapeutics Holdings, Inc. | 230.91M |
| Capricor Therapeutics, Inc. | 318.13M |
| ADMA Biologics, Inc. | 87.63M |
| Akebia Therapeutics, Inc. | 186.54M |